As proof-of-concept, carbohydrate antigen 15-3 (CA15-3) and carcinoembryonic antigen (CEA) were selected as target biomarkers for breast cancer screening and broader cancer indication, respectively. The gene discussed is CEACAM5; the disease is cancer.